Dimensional Fund Advisors Portfolio holdings
Dimensional Fund Advisors (DFA), founded in 1981 by David Booth and Rex Sinquefield and headquartered in Austin, Texas, is an investment management firm renowned for its evidence-based, low-cost approach to investing, grounded in academic research from Nobel laureates like Eugene Fama and Kenneth French. Managing hundreds of billions in assets, DFA focuses on systematic, passive strategies that tilt toward factors like small-cap, value, and profitability stocks, primarily through mutual funds and institutional portfolios rather than retail brokerage services. The firm’s philosophy eschews market timing and stock picking, instead emphasizing diversification and efficient market exposure, often requiring investors to access its funds through approved financial advisors. With a global presence and a reputation for disciplined, data-driven investing, DFA has carved a unique niche in the industry, blending academic rigor with practical application.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Merck
MRK
|
+$462M |
| 2 |
NVIDIA
NVDA
|
+$385M |
| 3 |
Meta Platforms (Facebook)
META
|
+$311M |
| 4 |
Apple
AAPL
|
+$301M |
| 5 |
EXE
Expand Energy Corp
EXE
|
+$294M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
SWN
Southwestern Energy Company
SWN
|
+$381M |
| 2 |
ExxonMobil
XOM
|
+$352M |
| 3 |
MRO
Marathon Oil Corporation
MRO
|
+$223M |
| 4 |
VSTO
Vista Outdoor Inc.
VSTO
|
+$136M |
| 5 |
SoFi Technologies
SOFI
|
+$135M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.43% |
| 2 | Financials | 18.32% |
| 3 | Industrials | 12.44% |
| 4 | Consumer Discretionary | 10.89% |
| 5 | Healthcare | 9.55% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3301
ALX Oncology
ALXO
$269M
| $43.8K | ﹤0.01% |
26,233
-11,413
| -30% | -$17.5K |
|
3302
Drilling Tools International
DTI
$78.7M
| $43.1K | ﹤0.01% |
+13,224
| New | +$45.5K |
|
3303
PharmaCyte Biotech
PMCB
$6.44M
| $41.6K | ﹤0.01% |
26,841
-760
| -3% | -$1.31K |
|
|
CGC
3304
Canopy Growth
CGC
$381M
| $41.4K | ﹤0.01% |
+15,099
| New | +$59.9K |
|
3305
IRIDEX
IRIX
$15.4M
| $41.1K | ﹤0.01% |
24,438
| – | – |
|
3306
Battalion Oil
BATL
$28.4M
| $40.7K | ﹤0.01% |
23,560
| – | – |
|
3307
Dominari Holdings
DOMH
$53.1M
| $39.7K | ﹤0.01% |
39,833
| – | – |
|
3308
Beam Global
BEEM
$22.9M
| $39.2K | ﹤0.01% |
+12,376
| New | +$50.8K |
|
3309
Educational Development Corp
EDUC
$12.3M
| $37.5K | ﹤0.01% |
22,753
+1,889
| +9% | +$3.65K |
|
3310
Arts-Way Manufacturing Co
ARTW
$13M
| $36.4K | ﹤0.01% |
16,797
-4,255
| -20% | -$7.22K |
|
|
CMBM
3311
DELISTED
Cambium Networks
CMBM
| $35.1K | ﹤0.01% |
54,167
-61,160
| -53% | -$72K |
|
|
FORA
3312
DELISTED
Forian
FORA
| $32.1K | ﹤0.01% |
15,592
+550
| +4% | +$1.14K |
|
|
CARV
3313
DELISTED
Carver Bancorp
CARV
| $31.7K | ﹤0.01% |
17,408
| – | – |
|
3314
Cocrystal Pharma
COCP
$13.2M
| $30.3K | ﹤0.01% |
15,015
+923
| +7% | +$1.85K |
|
3315
PDS Biotechnology
PDSB
$38.1M
| $30K | ﹤0.01% |
18,390
-6,908
| -27% | -$18.3K |
|
3316
Sphere 3D
ANY
$17.1M
| $29.9K | ﹤0.01% |
3,164
-4,162
| -57% | -$48.4K |
|
|
KLRS
3317
Kalaris Therapeutics
KLRS
$81.8M
| $29.5K | ﹤0.01% |
3,033
| – | – |
|
3318
Immuneering
IMRX
$271M
| $29.4K | ﹤0.01% |
13,366
| – | – |
|
3319
ReWalk Robotics
LFWD
$19.6M
| $29.3K | ﹤0.01% |
1,413
-171
| -11% | -$4.51K |
|
|
LGO
3320
Largo
LGO
$61.4M
| $29K | ﹤0.01% |
16,872
| – | – |
|
3321
Immunic
IMUX
$180M
| $27.5K | ﹤0.01% |
2,752
| – | – |
|
3322
Century Therapeutics
IPSC
$361M
| $27.1K | ﹤0.01% |
26,874
-6,575
| -20% | -$8.95K |
|
|
TMQ
3323
Trilogy Metals
TMQ
$511M
| $25.2K | ﹤0.01% |
21,693
| – | – |
|
|
AFMD
3324
DELISTED
Affimed
AFMD
| $21.6K | ﹤0.01% |
18,120
| – | – |
|
3325
Great Elm Group
GEG
$67.4M
| $20.7K | ﹤0.01% |
11,419
| – | – |
|
Similar funds
Dimensional Fund Advisors's Q4 2024 Portfolio in Review
As of Q4 2024, Dimensional Fund Advisors held 3,410 positions worth $416B, up 0.99% from $412B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Trading was light in Q4 2024: portfolio turnover was 3.9%. Dimensional Fund Advisors opened 61 new positions and exited 71, leaving the 3,410-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 20% a quarter earlier, followed by Financials and Industrials.
- Dimensional Fund Advisors's largest Q4 2024 buy was Everus Construction Group: 1,833,827 shares worth $121M.
- Dimensional Fund Advisors added most to Merck in Q4 2024, an estimated $462M increase.
- Dimensional Fund Advisors's biggest Q4 2024 reduction was ExxonMobil, cutting an estimated $352M.
- Dimensional Fund Advisors fully exited Southwestern Energy Company in Q4 2024, selling an estimated $381M.
- Dimensional Fund Advisors's ten largest holdings make up 16% of its $416B portfolio in Q4 2024.
- Dimensional Fund Advisors opened 61 new positions and closed 71 in Q4 2024.
- Dimensional Fund Advisors's portfolio value rose 0.99% quarter-over-quarter to $416B.
Based on Dimensional Fund Advisors's 13F filing for Q4 2024, filed 13 Feb 2025.